BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27311769)

  • 1. Nestin expression on tumour vessels and tumour-infiltrating macrophages define a poor prognosis subgroup of pt1 clear cell renal cell carcinoma.
    Cros J; Sbidian E; Posseme K; Letierce A; Guettier C; Benoît G; Ferlicot S
    Virchows Arch; 2016 Sep; 469(3):331-7. PubMed ID: 27311769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour cell expression of interleukin 6 receptor α is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma.
    Pilskog M; Bostad L; Edelmann RJ; Akslen LA; Beisland C; Straume O
    J Pathol Clin Res; 2018 Apr; 4(2):114-123. PubMed ID: 29665322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma.
    Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y
    Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma.
    Tessier-Cloutier B; Twa DD; Marzban M; Kalina J; Chun HE; Pavey N; Tanweer Z; Katz RL; Lum JJ; Salina D
    J Pathol Clin Res; 2021 Jul; 7(4):385-396. PubMed ID: 33665979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.
    Dall'Oglio MF; Antunes AA; Sarkis AS; Crippa A; Leite KR; Lucon AM; Srougi M
    BJU Int; 2007 Sep; 100(3):552-5. PubMed ID: 17555475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
    Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
    J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
    Shim M; Song C; Park S; Choi SK; Cho YM; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2213-20. PubMed ID: 26215891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma.
    Xu L; Zhu Y; Chen L; An H; Zhang W; Wang G; Lin Z; Xu J
    Ann Surg Oncol; 2014 Sep; 21(9):3142-50. PubMed ID: 24615178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-10b is a prognostic marker in clear cell renal cell carcinoma.
    Khella HWZ; Daniel N; Youssef L; Scorilas A; Nofech-Mozes R; Mirham L; Krylov SN; Liandeau E; Krizova A; Finelli A; Cheng Y; Yousef GM
    J Clin Pathol; 2017 Oct; 70(10):854-859. PubMed ID: 28360191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
    Xu W; Jiang X; Guan C; Gu M
    Medicine (Baltimore); 2020 Nov; 99(46):e23181. PubMed ID: 33181696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.
    Qi L; Du J; Zhang Z; Diao L; Chen X; Yao X
    BJU Int; 2013 Aug; 112(4):E415-23. PubMed ID: 23879920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
    Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
    Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with advanced renal cell carcinoma.
    Muriel López C; Esteban E; Berros JP; Pardo P; Astudillo A; Izquierdo M; Crespo G; Sanmamed M; Fonseca PJ; Martínez-Camblor P
    Clin Genitourin Cancer; 2012 Dec; 10(4):262-70. PubMed ID: 22959659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications.
    Yao X; Qian CN; Zhang ZF; Tan MH; Kort EJ; Yang XJ; Resau JH; Teh BT
    Clin Cancer Res; 2007 Jan; 13(1):161-9. PubMed ID: 17200351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
    Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
    Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.
    Sacré A; Barthélémy P; Korenbaum C; Burgy M; Wolter P; Dumez H; Lerut E; Loyson T; Joniau S; Oyen R; Debruyne PR; Schöffski P; Beuselinck B
    Acta Oncol; 2016; 55(3):329-40. PubMed ID: 26494607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.